<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Simparica Trio antiparasiticide for dogs set for launch in spring 2020 after gaining EC marketing authorisation</title><link>/b/veterinary-news/posts/simparica-trio-antiparasiticide-for-dogs-set-for-launch-in-spring-2020-after-gaining-ec-marketing-authorisation</link><description> Zoetis has announced that it plans to launch Simparica Trio (sarolaner/moxidectin/pyrantel) chewable tablets, a once-monthly triple combination antiparasitic medication for dogs with, or at risk from, mixed external and internal parasitic infestations</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>